Developer docs
API playgroundTry for free, no card

Search company profiles

Novosense

Full company profile

uuid000frq6

Namestring
Novosense
Legal namestring
Novosense AB
Websiteurl
novosense.se
Company typeenum
Private
Founded yearint
2004
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLund, Sweden
HQ citystring
Lund
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
wireless ECG monitoring, cardiac monitoring devices, medical wearable sensors, patient monitoring systems, ECG telemetry systems
Industry2 codes
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Wireless ECG Monitoring Systems
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1CardioSenseSystem Product Sales
TypeHardware Sales
Description

Novosense sells its CardioSenseSystem including CardioPatch sensors (single-use disposable), Access Points (multi-use), Server Software, and Information Centre monitoring software. The business model combines hardware sales (sensors, access points) with software licensing.

novosense.se
2CardioPatch Sensor Consumables
TypeSubscription Recurring
Description

Single-use CardioPatch sensors represent recurring consumable revenue. Each sensor operates for 48 hours and is replaced, creating a recurring revenue stream tied to patient monitoring hours.

novosense.se
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1CardioSenseSystem product line - pricing not publicly disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based / Not publicly disclosed. The system includes CardioPatch sensors (single-use), Access Points (multi-use), Server Software, and Information Centre Software. Health economic study indicates 65-85% reduction in acquisition costs compared to conventional systems.

novosense.se
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1CardioSenseSystem®
Description

CE-certified AI-enhanced ECG monitoring system consisting of CardioPatch sensors, Access Point, server software, and Information Centre monitoring software.

novosense.se
+3 more records
Core offering1 text field

Novosense designs, manufactures, and sells the CardioSenseSystem, a CE-certified cable-free continuous ECG monitoring system for hospitals. The system bundles single-use self-adhesive CardioPatch wireless sensors (48-hour operation), multi-use Access Point receivers, Server Software, and Information Centre monitoring software, enabling AI-driven arrhythmia detection with no cables, no sterilization, and reduced false alarms.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 30× higher sensitivity: 364 vs 12 critical alarms (p < 0.0001)
+7 more records
Product overview1 text field

Novosense offers a unified ECG monitoring platform called CardioSenseSystem®, consisting of three smart patches (CardioPatch® sensors), a multi-use Access Point, Server Software, and Information Centre monitoring software. The system operates as a complete cable-free ECG monitoring solution where CardioPatch sensors continuously transmit ECG data to the Access Point, which relays information to the Server Software for storage and processing, displayed through the Information Centre for clinical staff monitoring.

Product and service5 records
1CardioSenseSystem
CategoryWireless ECG Monitoring System
Description

CE-certified (MDR No. 766007) cable-free, AI-enhanced continuous ECG monitoring system for hospital cardiac care, intensive care, and operating theatres. Combines single-use CardioPatch sensors, multi-use Access Point, Server Software, and Information Centre monitoring software into one platform for clinical staff.

2CardioPatch
CategoryWireless ECG Sensor (Consumable)
Description

Wireless, self-adhesive single-use ECG sensor applied to the body like a traditional electrode. Operates 48 hours, defibrillation-proof, waterproof, with 1000 Hz sampling frequency and automatic activation on removal from tray. For hospital ECG monitoring in adult patients.

3Novosense Access Point
CategoryWireless Receiver Infrastructure
Description

Multi-use high-capacity radio receiver that collects wireless ECG data from up to 16 patients (up to 80 CardioPatches) simultaneously and relays the information to the server. Also designed to receive data from pulse oximeters, blood pressure sensors, and respiratory sensors.

4Novosense Server Software
CategoryECG Server Software
Description

Server software that calculates and stores ECG data in an SQL database and broadcasts information to the Information Centre. Configurable to support up to 255 Information Centre clients simultaneously. Used by hospital IT and clinical engineering teams.

5Novosense Information Centre
CategoryClinical Monitoring Software
Description

Monitoring software that continuously displays patient ECG curves with audio and visual alarms for critical events. Monitors up to 16 patients simultaneously, supports dual screens, and analyzes trends, alarms, curves, and ST segments for clinical staff at nursing stations.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1EU Horizon ICT Programme Consortium
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-03-04
Description

Novosense and partners awarded €4 million in EU Horizon ICT programme for SmartVista project. Partners include Tyndall National Institute, Fraunhof-EMFT, CNRS, UCC, Analog Devices, and Novosense. The goal is to develop a smart cardiac monitoring patch powered by body heat for digital healthcare.

novosense.se
2SmartVista Project Partners (Tyndall, Fraunhof-EMFT, CNRS, UCC, Analog Devices)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EU Horizon project developing self-powered cardiac monitoring device using 1D/2D nanomaterial-based sensors, thermoelectric energy harvesters, and printable battery systems. Project positions Novosense at forefront of digital health and wearable biosensor technology.

novosense.se
3VitalHomeHealthCare Project Consortium
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Eurostars project to develop miniaturized self-contained wireless wearable sensor for home health care vital signs monitoring. Primary vital signs are breathing and ECG. UWB radar technology used for breathing monitoring implemented on single CMOS chip.

novosense.se
4NextGenECG Project
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Eurostars project developing cable-free ECG monitoring system consisting of ECG sensor, ECG base station, and back-end ECG system. Novel technology enables ECG monitoring without cables attached to the body.

novosense.se
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Founding research collaborator in the establishment of Novosense AB as a research collaboration between Acreo AB, Tilly Medical AB, and Fredrik Sebelius (Lund University).

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Founding research collaborator in the establishment of Novosense AB as a research collaboration between Acreo AB, Tilly Medical AB, and Fredrik Sebelius (Lund University).

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic founding research collaborator through Fredrik Sebelius in the establishment of Novosense AB. Company maintains close cooperation with Lund University, the largest university in Scandinavia, located at Ideon Science Park.

8Thoracic Surgery Department, Lund, Sweden
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical trial site for CardioSenseSystem comparative study. Department has well-documented expertise in heart surgery and is one of two places in Sweden that carry out heart transplantation. Study sponsored by Novosense AB.

novosense.se
9The Swedish Institute for Health Economics (IHE)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Conducted health economic study of CardioSenseSystem at Skåne University Hospital, demonstrating cost advantages including 65-85% reduction in acquisition costs and 76-79% reduction in staff costs.

novosense.se
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Health economic study site for CardioSenseSystem including four inpatient wards. Study demonstrated superior performance and significant cost reductions compared to existing ECG systems.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

VivaLNK makes wearable medical sensors and continuous vital-sign patches for both clinical and remote patient monitoring. It overlaps with Novosense's wireless patch technology but focuses more on RPM platforms and partners rather than direct hospital sales.

TypeBroad incumbent
Description

GE HealthCare offers CARESCAPE and bedside ECG/telemetry systems serving the same ICU and step-down unit customers as Novosense. It is a broad incumbent whose monitoring business sits alongside imaging, ultrasound, and pharmaceuticals.

TypeBroad incumbent
Description

Hillrom (acquired by Baxter) offered connected bed and vital-sign monitoring solutions in hospital settings, overlapping with Novosense's patient monitoring focus. As a broad incumbent, it competes across multiple care delivery touchpoints.

4Dräger (Infinity Patient Monitoring)
TypeBroad incumbent
Description

Dräger's Infinity patient monitoring platform is widely deployed in European hospitals for ICU and peri-operative ECG monitoring, directly competing with Novosense's cable-free approach. Dräger is a broader acute-care-focused medtech incumbent.

TypeDirect peer
Description

Boston Scientific (via its Preventice acquisition) offers the BodyGuardian family of wearable cardiac sensors for continuous ECG and remote monitoring. It competes directly with Novosense in the wireless ambulatory/in-hospital ECG patch category.

6Nihon Kohden
TypeBroad incumbent
Description

Nihon Kohden is a Japanese medtech company whose patient monitoring and ECG product lines serve hospitals globally, including European ICUs. It is a direct functional competitor to Novosense's CardioSenseSystem.

TypeBroad incumbent
Description

Philips is a global leader in hospital patient monitoring with bedside telemetry and IntelliVue ECG systems used in ICUs and cardiac care units. It competes with Novosense in the same hospital ECG monitoring category but as part of a much broader portfolio including imaging and informatics.

TypeDirect peer
Description

iRhythm's Zio patch is a wearable, single-use continuous ECG monitor that directly competes with Novosense's CardioPatch on cable-free, long-duration cardiac monitoring. While iRhythm is primarily US-focused on ambulatory diagnostics, the core patch-based technology and use case are highly comparable.

TypeBroad incumbent
Description

Mindray's BeneVision patient monitoring system targets the same hospital ICU and cardiac care units as Novosense with multi-parameter bedside monitors. It is a Chinese-headquartered incumbent that has expanded aggressively in Europe.

TypeDirect peer
Description

Spacelabs Healthcare provides bedside and telemetry ECG monitoring systems for hospitals, overlapping directly with Novosense's target ICU and step-down unit customers. It is a more focused, mid-size patient monitoring specialist compared to the broad incumbents.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Novosense

Wireless ECG Monitoring Systemsnovosense.se

Novosense firmographics

Firmographics
Name
Novosense
Legal name
Novosense AB
Website
https://novosense.se
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Novosense industry classification

Industry
Product category
Wireless ECG Monitoring Systems
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAI
Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Wireless ECG monitoring
  • Cardiac monitoring devices
  • Medical wearable sensors
  • Patient monitoring systems
  • ECG telemetry systems

Where Novosense is headquartered

Location

Headquarters

HQ city
Lund
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Novosense business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. CardioSenseSystem Product Sales: Novosense sells its CardioSenseSystem including CardioPatch sensors (single-use disposable), Access Points (multi-use), Server Software, and Information Centre monitoring software. The business model combines hardware sales (sensors, access points) with software licensing.
  2. CardioPatch Sensor Consumables: Single-use CardioPatch sensors represent recurring consumable revenue. Each sensor operates for 48 hours and is replaced, creating a recurring revenue stream tied to patient monitoring hours.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCardioSenseSystem product line - pricing not publicly disclosed

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Novosense product offering

Product offering

Core offering

Novosense designs, manufactures, and sells the CardioSenseSystem, a CE-certified cable-free continuous ECG monitoring system for hospitals. The system bundles single-use self-adhesive CardioPatch wireless sensors (48-hour operation), multi-use Access Point receivers, Server Software, and Information Centre monitoring software, enabling AI-driven arrhythmia detection with no cables, no sterilization, and reduced false alarms.

Product overview

Novosense offers a unified ECG monitoring platform called CardioSenseSystem®, consisting of three smart patches (CardioPatch® sensors), a multi-use Access Point, Server Software, and Information Centre monitoring software. The system operates as a complete cable-free ECG monitoring solution where CardioPatch sensors continuously transmit ECG data to the Access Point, which relays information to the Server Software for storage and processing, displayed through the Information Centre for clinical staff monitoring.

Differentiator

Problem solved

Functional benefit

Brands

  • CardioSenseSystem®: CE-certified AI-enhanced ECG monitoring system consisting of CardioPatch sensors, Access Point, server software, and Information Centre monitoring software.
  • CardioPatch®
  • Novosense Access Point
  • SafeNovo®

Products and services

  • CardioSenseSystem CE-certified (MDR No. 766007) cable-free, AI-enhanced continuous ECG monitoring system for hospital cardiac care, intensive care, and operating theatres. Combines single-use CardioPatch sensors, multi-use Access Point, Server Software, and Information Centre monitoring software into one platform for clinical staff.
  • CardioPatch Wireless, self-adhesive single-use ECG sensor applied to the body like a traditional electrode. Operates 48 hours, defibrillation-proof, waterproof, with 1000 Hz sampling frequency and automatic activation on removal from tray. For hospital ECG monitoring in adult patients.
  • Novosense Access Point Multi-use high-capacity radio receiver that collects wireless ECG data from up to 16 patients (up to 80 CardioPatches) simultaneously and relays the information to the server. Also designed to receive data from pulse oximeters, blood pressure sensors, and respiratory sensors.
  • Novosense Server Software Server software that calculates and stores ECG data in an SQL database and broadcasts information to the Information Centre. Configurable to support up to 255 Information Centre clients simultaneously. Used by hospital IT and clinical engineering teams.
  • Novosense Information Centre Monitoring software that continuously displays patient ECG curves with audio and visual alarms for critical events. Monitors up to 16 patients simultaneously, supports dual screens, and analyzes trends, alarms, curves, and ST segments for clinical staff at nursing stations.

Quantifiable outcome

  • 30× higher sensitivity: 364 vs 12 critical alarms (p < 0.0001)
  • +7 more outcomes

Companies that use Novosense

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Novosense technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Novosense partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • EU Horizon ICT Programme ConsortiumcoreStrategic or Co-development Partner · 4 March 2019Novosense and partners awarded €4 million in EU Horizon ICT programme for SmartVista project. Partners include Tyndall National Institute, Fraunhof-EMFT, CNRS, UCC, Analog Devices, and Novosense. The goal is to develop a smart cardiac monitoring patch powered by body heat for digital healthcare.
  • SmartVista Project Partners (Tyndall, Fraunhof-EMFT, CNRS, UCC, Analog Devices)coreStrategic or Co-development PartnerEU Horizon project developing self-powered cardiac monitoring device using 1D/2D nanomaterial-based sensors, thermoelectric energy harvesters, and printable battery systems. Project positions Novosense at forefront of digital health and wearable biosensor technology.
  • VitalHomeHealthCare Project ConsortiumminorStrategic or Co-development PartnerEurostars project to develop miniaturized self-contained wireless wearable sensor for home health care vital signs monitoring. Primary vital signs are breathing and ECG. UWB radar technology used for breathing monitoring implemented on single CMOS chip.
  • NextGenECG ProjectminorStrategic or Co-development PartnerEurostars project developing cable-free ECG monitoring system consisting of ECG sensor, ECG base station, and back-end ECG system. Novel technology enables ECG monitoring without cables attached to the body.
  • Acreo ABminorStrategic or Co-development PartnerFounding research collaborator in the establishment of Novosense AB as a research collaboration between Acreo AB, Tilly Medical AB, and Fredrik Sebelius (Lund University).
  • Tilly Medical ABminorStrategic or Co-development PartnerFounding research collaborator in the establishment of Novosense AB as a research collaboration between Acreo AB, Tilly Medical AB, and Fredrik Sebelius (Lund University).
  • Lund UniversityminorStrategic or Co-development PartnerAcademic founding research collaborator through Fredrik Sebelius in the establishment of Novosense AB. Company maintains close cooperation with Lund University, the largest university in Scandinavia, located at Ideon Science Park.
  • Thoracic Surgery Department, Lund, SwedencoreStrategic or Co-development PartnerClinical trial site for CardioSenseSystem comparative study. Department has well-documented expertise in heart surgery and is one of two places in Sweden that carry out heart transplantation. Study sponsored by Novosense AB.
  • The Swedish Institute for Health Economics (IHE)coreStrategic or Co-development PartnerConducted health economic study of CardioSenseSystem at Skåne University Hospital, demonstrating cost advantages including 65-85% reduction in acquisition costs and 76-79% reduction in staff costs.
  • Skåne University HospitalcoreStrategic or Co-development PartnerHealth economic study site for CardioSenseSystem including four inpatient wards. Study demonstrated superior performance and significant cost reductions compared to existing ECG systems.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Novosense competitors and assessment

Company assessment

Emerging players

  • VivaLNK: VivaLNK makes wearable medical sensors and continuous vital-sign patches for both clinical and remote patient monitoring. It overlaps with Novosense's wireless patch technology but focuses more on RPM platforms and partners rather than direct hospital sales.

Broad incumbents

  • GE HealthCare (Patient Monitoring): GE HealthCare offers CARESCAPE and bedside ECG/telemetry systems serving the same ICU and step-down unit customers as Novosense. It is a broad incumbent whose monitoring business sits alongside imaging, ultrasound, and pharmaceuticals.
  • Hillrom (now part of Baxter): Hillrom (acquired by Baxter) offered connected bed and vital-sign monitoring solutions in hospital settings, overlapping with Novosense's patient monitoring focus. As a broad incumbent, it competes across multiple care delivery touchpoints.
  • Dräger (Infinity Patient Monitoring): Dräger's Infinity patient monitoring platform is widely deployed in European hospitals for ICU and peri-operative ECG monitoring, directly competing with Novosense's cable-free approach. Dräger is a broader acute-care-focused medtech incumbent.
  • Nihon Kohden: Nihon Kohden is a Japanese medtech company whose patient monitoring and ECG product lines serve hospitals globally, including European ICUs. It is a direct functional competitor to Novosense's CardioSenseSystem.
  • Philips (Patient Monitoring): Philips is a global leader in hospital patient monitoring with bedside telemetry and IntelliVue ECG systems used in ICUs and cardiac care units. It competes with Novosense in the same hospital ECG monitoring category but as part of a much broader portfolio including imaging and informatics.
  • Mindray (BeneVision): Mindray's BeneVision patient monitoring system targets the same hospital ICU and cardiac care units as Novosense with multi-parameter bedside monitors. It is a Chinese-headquartered incumbent that has expanded aggressively in Europe.

Direct peers

  • Boston Scientific / Preventice (BodyGuardian): Boston Scientific (via its Preventice acquisition) offers the BodyGuardian family of wearable cardiac sensors for continuous ECG and remote monitoring. It competes directly with Novosense in the wireless ambulatory/in-hospital ECG patch category.
  • iRhythm Technologies (Zio): iRhythm's Zio patch is a wearable, single-use continuous ECG monitor that directly competes with Novosense's CardioPatch on cable-free, long-duration cardiac monitoring. While iRhythm is primarily US-focused on ambulatory diagnostics, the core patch-based technology and use case are highly comparable.
  • Spacelabs Healthcare (Patient Monitoring): Spacelabs Healthcare provides bedside and telemetry ECG monitoring systems for hospitals, overlapping directly with Novosense's target ICU and step-down unit customers. It is a more focused, mid-size patient monitoring specialist compared to the broad incumbents.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Novosense social profiles

Digital presence

Novosense compliance and trust

Trust signal

Compliance1 record

Novosense financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Novosense leadership team

Management profile

Number of profiles

Profiles2 records

Novosense funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Novosense M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novosense

What does Novosense do?

Novosense designs, manufactures, and sells the CardioSenseSystem, a CE-certified cable-free continuous ECG monitoring system for hospitals. The system bundles single-use self-adhesive CardioPatch wireless sensors (48-hour operation), multi-use Access Point receivers, Server Software, and Information Centre monitoring software, enabling AI-driven arrhythmia detection with no cables, no sterilization, and reduced false alarms.

Is Novosense a public or private company?

Novosense is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Novosense founded?

Novosense was founded in 2004. It employs 1 to 10 people.

Where is Novosense based?

Novosense is headquartered in Lund, Sweden, in the Europe region.

How does Novosense make money?

Two revenue lines are on record. CardioSenseSystem Product Sales are the primary driver. The others are cardioPatch Sensor Consumables.

Who are Novosense's main competitors?

VivaLNK is listed as an emerging player. Broad incumbents are GE HealthCare (Patient Monitoring), Hillrom (now part of Baxter), Dräger (Infinity Patient Monitoring), Nihon Kohden, Philips (Patient Monitoring) and Mindray (BeneVision). Direct peers are Boston Scientific / Preventice (BodyGuardian), iRhythm Technologies (Zio) and Spacelabs Healthcare (Patient Monitoring).

Does Novosense have an API?

No public API is recorded for Novosense.

What industry is Novosense in?

Novosense's product category is Wireless ECG Monitoring Systems. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR Newswire APACNOVOSENSE Presents Semiconductor Technologies for xEV Powertrain and ADAS at Automotive Engineering Exposition 2026NOVOSENSE will exhibit automotive semiconductor solutions for xEV powertrain and ADAS at Automotive Engineering Exposition 2026 in Yokohama. The company reported US$495 million revenue in 2025, with automotive contributing over 35%, and annual chip shipments exceeding 750 million. The same portfolio will be shown at the Nagoya expo in June.TheautochannelNOVOSENSE Expands SafeNovo® Portfolio for Automotive Functional Safety ApplicationsNOVOSENSE announced the expansion of its SafeNovo® portfolio for automotive functional safety applications, including the ASIL D-certified NSI6911F isolated gate driver for high-voltage powertrain systems and additional ASIL B products for ultrasonic sensing, LED lighting, and wheel-speed detection applications. The company's automotive business generated approximately US$495 million in 2025 revenue (over 35% of total), with Q1 2026 revenue reaching US$168 million, up 59.17% year on year. NOVOSENSE will showcase these solutions at PCIM Europe 2026 and SENSOR+TEST 2026, both held in Nuremberg, Germany.PR NewswireNOVOSENSE improves industrial system design with one-chip isolated power supplyNOVOSENSE introduced the NIRSP31, a single-chip isolated power supply integrating isolated power and three-channel digital isolators. The chip reduces PCB area and height compared to traditional modules, and is applied in E-bike, battery storage, and industrial metering. Demo boards are available for evaluation.